Damora Therapeutics (DMRA) Stock: Why It's Up Today

Updated Oct 19, 2026, 4:00 PM ET · closing price

What changed since yesterday

Closed at $19.27, +4.50% vs the prior close of $18.44.
Volume 293.08K shares, 0.5x its 50-day average (light).
No new SEC filings since the prior session.
No new insider buys or sales reported since the prior session.

DMRA jumps 4.5% to $19.27. Closed at $19.27, +4.50% vs the prior close of $18.44. Day range $18.51–$19.83, opened at $18.56.

Last close$19.27+4.50%

Day range18.51–19.83

Open18.56

Volume293.08K

52-week range4.95–38.33

Avg volume (20d)573.81K

DMRA daily analysis — what happened

A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.

Oct 19, 2026 — DMRA jumps 4.5% to $19.27

Closed at $19.27, +4.50% vs the prior close of $18.44. Day range $18.51–$19.83, opened at $18.56.
Volume was 293.08K shares, 0.5x its 50-day average of 550.48K — lighter than usual.
Price is -23.6% vs its 50-day average ($25.23) and -24.9% vs its 200-day average ($25.67).
52-week range $4.95–$38.33; today's close sits at 43% of that range, 49.7% below the 52-week high.

Oct 16, 2026 — DMRA dips 1.6% to $18.44

Closed at $18.44, -1.60% vs the prior close of $18.74. Day range $17.49–$18.80, opened at $18.69.
Volume was 836.71K shares, 1.5x its 50-day average of 547.68K.
Price is -27.5% vs its 50-day average ($25.44) and -28.2% vs its 200-day average ($25.69).
52-week range $4.95–$38.33; today's close sits at 40% of that range, 51.9% below the 52-week high.

Oct 15, 2026 — DMRA rises 1.7% to $18.74

Closed at $18.74, +1.68% vs the prior close of $18.43. Day range $17.84–$18.89, opened at $18.59.
Volume was 357.60K shares, 0.6x its 50-day average of 552.67K.
Price is -27.0% vs its 50-day average ($25.67) and -27.1% vs its 200-day average ($25.71).
52-week range $4.95–$38.33; today's close sits at 41% of that range, 51.1% below the 52-week high.

Oct 14, 2026 — DMRA dips 0.7% to $18.43, a 6-month low, 3 down days in a row

Closed at $18.43, -0.70% vs the prior close of $18.56. Day range $18.00–$18.98, opened at $18.21.
Volume was 277.60K shares, 0.5x its 50-day average of 558.14K — lighter than usual.
Price is -28.9% vs its 50-day average ($25.92) and -28.5% vs its 200-day average ($25.77).
52-week range $4.95–$38.33; today's close sits at 40% of that range, 51.9% below the 52-week high.
That makes 3 straight losses.

Oct 13, 2026 — DMRA slides 8.4% to $18.56, a 6-month low

Closed at $18.56, -8.37% vs the prior close of $20.25. Day range $18.50–$20.28, opened at $20.09.
Volume was 285.20K shares, 0.5x its 50-day average of 556.99K — lighter than usual.
Price is -29.0% vs its 50-day average ($26.15) and -28.2% vs its 200-day average ($25.84).
52-week range $4.95–$38.33; today's close sits at 41% of that range, 51.6% below the 52-week high.

Oct 12, 2026 — DMRA slides 3.9% to $20.25

Closed at $20.25, -3.91% vs the prior close of $21.08. Day range $20.05–$21.26, opened at $20.93.
Volume was 267.90K shares, 0.5x its 50-day average of 557.93K — lighter than usual.
Price is -23.1% vs its 50-day average ($26.35) and -21.8% vs its 200-day average ($25.90).
52-week range $4.95–$38.33; today's close sits at 46% of that range, 47.1% below the 52-week high.

Oct 9, 2026 — DMRA rises 2.5% to $21.08, 3 up days in a row

Closed at $21.08, +2.53% vs the prior close of $20.56. Day range $20.43–$21.86, opened at $20.53.
Volume was 368.70K shares, 0.7x its 50-day average of 557.23K.
Price is -20.5% vs its 50-day average ($26.52) and -18.7% vs its 200-day average ($25.94).
52-week range $4.95–$38.33; today's close sits at 48% of that range, 45.0% below the 52-week high.
That makes 3 straight gains.

Oct 8, 2026 — DMRA rises 1.6% to $20.56

Closed at $20.56, +1.58% vs the prior close of $20.24. Day range $19.22–$20.87, opened at $19.96.
Volume was 341.80K shares, 0.6x its 50-day average of 556.86K.
Price is -23.0% vs its 50-day average ($26.68) and -20.9% vs its 200-day average ($25.98).
52-week range $4.95–$38.33; today's close sits at 47% of that range, 46.4% below the 52-week high.

Oct 7, 2026 — DMRA jumps 3.5% to $20.24

Closed at $20.24, +3.53% vs the prior close of $19.55. Day range $18.69–$20.35, opened at $19.36.
Volume was 488.80K shares, 0.9x its 50-day average of 553.19K.
Price is -24.6% vs its 50-day average ($26.84) and -22.2% vs its 200-day average ($26.02).
52-week range $4.95–$38.33; today's close sits at 46% of that range, 47.2% below the 52-week high.

Oct 6, 2026 — DMRA slides 3.3% to $19.55, a 6-month low on 2.2x normal volume

Closed at $19.55, -3.31% vs the prior close of $20.22. Day range $18.19–$20.48, opened at $20.42.
Volume was 1.17M shares, 2.2x its 50-day average of 540.70K — unusually heavy trading.
Price is -27.7% vs its 50-day average ($27.02) and -24.9% vs its 200-day average ($26.04).
52-week range $3.64–$38.33; today's close sits at 46% of that range, 49.0% below the 52-week high.

Oct 5, 2026 — DMRA dips 2.1% to $20.22, a 3-month low

Closed at $20.22, -2.08% vs the prior close of $20.65. Day range $19.54–$20.69, opened at $20.64.
Volume was 556.10K shares, 1.0x its 50-day average of 540.88K.
Price is -25.7% vs its 50-day average ($27.22) and -22.5% vs its 200-day average ($26.08).
52-week range $3.64–$38.33; today's close sits at 48% of that range, 47.2% below the 52-week high.

Oct 2, 2026 — DMRA rises 2.1% to $20.65

Closed at $20.65, +2.08% vs the prior close of $20.23. Day range $19.59–$20.76, opened at $20.55.
Volume was 692.90K shares, 1.3x its 50-day average of 536.80K.
Price is -24.6% vs its 50-day average ($27.39) and -21.0% vs its 200-day average ($26.13).
52-week range $3.50–$38.33; today's close sits at 49% of that range, 46.1% below the 52-week high.

DMRA bull case vs bear case (from the data)

Bull case

Insiders made 4 open-market purchases in the last 12 months.

Bear case

Price is -23.6% vs its 50-day average — short-term trend is down.
Price is -24.9% vs its 200-day average — below the long-term trend line.
Latest fiscal-year net income: loss of $209.84M.
Insider selling outweighs buying: 16 sales vs 4 open-market buys among the 20 most recent reported insider trades (Form 4, last 12 months).
Share count up 4560.8% in a year (dilution).

DMRA latest news & SEC filings

Every SEC filing by or about DMRA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 28, 2026 · Form 4 — Insider trade

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Jarrett Jennifer bought 12,500 shares at $20.23 (≈$252.88K) on Sep 25, 2026; now holds 512,500

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001193125-26-403355

Aug 13, 2026 · Form 4 — Insider trade

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001193125-26-349537

Aug 13, 2026 · Form 3 — New insider holdings

Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0001193125-26-349515

Aug 12, 2026 · Form EFFECT — EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-002630